LisaGiulinoRothMD

Pediatric Hematology & Oncology • New York, NY

Pediatric Hematologic Oncology

Assistant Professor of Pediatrics

Overview of Dr. Roth

Dr. Lisa Roth is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from New York University Grossman School of Medicine and has been in practice 12 years. She is one of 135 doctors at New York-Presbyterian Hospital and one of 37 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Pediatric Hematology & Oncology. She has more than 30 publications and over 500 citings.

Office
1275 York Ave
Department of Pediatrics
New York, NY 10065
Book by Phone+1(256) 513-6931

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2008 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
New York University School of MedicineClass of 2005

Certifications & Licensure

NY State Medical License 2006 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

10 citations
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma
Graham P. Collins, Toby A. Eyre, Debora Schmitz-Rohmer, William Townsend, Rakesh Popat
Hemasphere. 2021-11-01
63 citations
Therapeutic options for CTLA-4 insufficiency.
David Egg, Ina Caroline Rump, Noriko Mitsuiki, Jessica Rojas-Restrepo, Maria Elena Maccari
The Journal of Allergy and Clinical Immunology. 2021-06-07
18 citations
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
Lisa Giulino-Roth, Qinglin Pei, Allen Buxton, Rizvan Bush, Yue Wu
Blood. 2021-03-18

Abstracts/Posters

Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes
Lisa Giulino Roth, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin LymphomaDecember 8th, 2024
Lymphomas in the Young and the Old: How Do They Differ?September 10th, 2024
Awareness Increases of Unique Needs of AYA Lymphoma PatientsJune 21st, 2017